Understanding How Our Immune System Detects Bacterial Threats
Functional and Structural Dissection of Inflammasome Activation
This research helps us understand how our body's immune system recognizes and responds to dangerous bacteria like those causing anthrax and shigella infections.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11124606 on NIH RePORTER |
What this research studies
Our bodies have a built-in alarm system called the inflammasome that senses when harmful bacteria are present. This project looks closely at how a specific part of this system, called NLRP1, gets activated by toxins from bacteria like Bacillus anthracis (which causes anthrax) and Shigella flexneri. We found that these bacterial toxins trigger a unique process in NLRP1, essentially 'cutting' it in a way that turns on the immune response. By understanding these detailed steps, we hope to find new ways to fight off serious infections.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but aims to benefit individuals susceptible to or suffering from severe bacterial infections like anthrax or shigellosis in the future.
Not a fit: Patients without bacterial infections or those with conditions unrelated to inflammasome activation by bacterial toxins may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new strategies for treating severe bacterial infections by targeting how our immune system responds to them.
How similar studies have performed: Previous work by this team has already successfully identified key molecular mechanisms by which the NLRP1 inflammasome is activated by bacterial toxins, building a strong foundation for this continued investigation.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Vance, Russell E — University of California Berkeley
- Study coordinator: Vance, Russell E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.